Company: SMNR
Filing Date: 2025-06-11
Form Type: S-4/A
Source: 0001193125-25-139124
Chunk: 75

Company: Semnur Pharmaceuticals, Inc.
Filing Date: 2025-06-11
Form: S-4/A
Chunk 75
---
 Denali Class B Ordinary Shares are entitled to vote on the Director Election Proposal. An abstention will count towards the quorum for the Meeting but will not otherwise be counted. Broker non-voteswill have no effect on the vote for the Director Election Proposal. Proposal 7 —The Nasdaq Proposal requires the affirmative vote of the majority of the Denali Ordinary Shares present in person or represented by proxy and entitled to vote thereon and who vote at the Meeting or any adjournment or postponement thereof. An abstention will count towards the quorum for the Meeting but will not otherwise be counted. Broker non-voteswill have no effect on the vote for the Nasdaq Proposal. Proposal 8 —The Option Exchange Proposal requires the affirmative vote of the majority of the Denali Ordinary Shares present in person or represented by proxy and entitled to vote thereon and who vote at the Meeting or any adjournment or postponement thereof. An abstention will count towards the quorum for the Meeting but will not otherwise be counted. Broker non-voteswill have no effect on the vote for the Option Exchange Proposal. Proposal 9 —The Adjournment Proposal requires the affirmative vote of the majority of the Denali Ordinary Shares present in person or represented by proxy and entitled to vote thereon and who vote at the Meeting or any adjournment or postponement thereof. An abstention will count towards the quorum for the Meeting but will not otherwise be counted. Broker non-voteswill have no effect on the vote for the Adjournment Proposal.

| Q: | Are any of the Proposals conditioned on one another? |

| Q: | How will the Initial Shareholders vote? |

| A: | Pursuant to a letter agreement, dated as of April 6, 2022, the Initial Shareholders agreed to attend the Meeting and vote their respective founder shares in favor of the Business Combination Proposal and other proposals (the “Letter Agreement”). In addition, in connection with the execution of the Merger Agreement, the Initial Shareholders entered into the Sponsor Support Agreement with Semnur, pursuant to which they agreed to vote all Denali Ordinary Shares beneficially owned by them in favor of the Proposals. As of the date of this proxy statement/prospectus, a total of 1,562,500 Denali Ordinary Shares, or approximately 59.7% of the issued and outstanding Denali Ordinary Shares, were subject to the Letter Agreement and the Sponsor Support Agreement. As a result, no Denali Class A Ordinary